ATE233788T1 - Interleukin-15-rezeptoren - Google Patents

Interleukin-15-rezeptoren

Info

Publication number
ATE233788T1
ATE233788T1 AT95918389T AT95918389T ATE233788T1 AT E233788 T1 ATE233788 T1 AT E233788T1 AT 95918389 T AT95918389 T AT 95918389T AT 95918389 T AT95918389 T AT 95918389T AT E233788 T1 ATE233788 T1 AT E233788T1
Authority
AT
Austria
Prior art keywords
interleukin
receptors
disclosed
dnas
receptor
Prior art date
Application number
AT95918389T
Other languages
English (en)
Inventor
Dirk M Anderson
Judith G Giri
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE233788T1 publication Critical patent/ATE233788T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95918389T 1994-05-06 1995-05-04 Interleukin-15-rezeptoren ATE233788T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23691994A 1994-05-06 1994-05-06
US08/300,903 US5591630A (en) 1994-05-06 1994-09-06 Monoclonal antibodies that bind interleukin-15 receptors
PCT/US1995/005585 WO1995030695A1 (en) 1994-05-06 1995-05-04 Interleukin-15 receptors

Publications (1)

Publication Number Publication Date
ATE233788T1 true ATE233788T1 (de) 2003-03-15

Family

ID=26930223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918389T ATE233788T1 (de) 1994-05-06 1995-05-04 Interleukin-15-rezeptoren

Country Status (11)

Country Link
US (1) US5591630A (de)
EP (1) EP0759942B1 (de)
AT (1) ATE233788T1 (de)
AU (1) AU695798B2 (de)
CA (1) CA2188279C (de)
DE (1) DE69529822T2 (de)
DK (1) DK0759942T3 (de)
ES (1) ES2193192T3 (de)
NZ (1) NZ285292A (de)
PT (1) PT759942E (de)
WO (1) WO1995030695A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548065B1 (en) * 1994-05-06 2003-04-15 Immunex Corporation Interleukin-15 receptors
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
ES2191827T3 (es) * 1996-10-17 2003-09-16 Immunomedics Inc Conjugado de toxina no antigenica y proteina de fusion de un sistema receptor de penetracion intracelular.
EP0971728B1 (de) * 1997-02-21 2002-12-11 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Verwendung von interleukin-15
WO2000001851A1 (en) * 1998-07-07 2000-01-13 Hisamitsu Pharmaceutical Co., Inc. Antisense oligonucleotides targeted to il-15
AU2001245428B2 (en) * 2000-03-03 2006-04-27 University Of Utah Research Foundation Mass1 gene, a target for anticonvulsant drug development
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
KR100911951B1 (ko) * 2001-08-23 2009-08-13 젠맵 에이/에스 인터루킨 15 (il-15)에 대하여 특이적인 인간 항체
WO2007001677A2 (en) 2005-05-17 2007-01-04 University Of Connecticut Compositions and methods for immunomodulation in an organism
EP1777294A1 (de) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi Domäin als selektieve und potente Enhancer von IL-15 Aktion durch IL-15Rbeta/gamma, und Hyperagonist (IL15Ralpha sushi -IL15) Fusionsproteine
EP2366787B1 (de) 2006-01-13 2019-12-11 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Codonoptimierte IL-15- und IL-15R-Alpha-Gene zur Expression von Säugetierzellen
EP2173378B1 (de) 2007-06-27 2014-03-19 Admune Therapeutics LLC Komplexe von il-15 und il-15ralpha und ihre verwendungen
WO2011020047A1 (en) 2009-08-14 2011-02-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of il-15 to increase thymic output and to treat lymphopenia
WO2011031986A1 (en) 2009-09-10 2011-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Assays for soluble il-15 receptor alpha
US20150359853A1 (en) 2012-10-24 2015-12-17 Admune Therapeutics Llc Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
JP2016518361A (ja) 2013-04-19 2016-06-23 シーチューヌ ファルマCytune Pharma 血管漏出症候群の発生を抑制するサイトカイン治療
US10335460B2 (en) 2014-07-29 2019-07-02 Novartis Ag IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
CN109715196A (zh) 2016-06-13 2019-05-03 转矩医疗股份有限公司 用于促进免疫细胞功能的组合物和方法
CA3074826A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
CN112795543B (zh) * 2021-02-04 2022-09-27 华中农业大学 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用
US20260048099A1 (en) 2022-08-16 2026-02-19 The United States Of America, As Represented By The Secretary, Deparment Of Health And Human Service Synergistic interactions for improved cancer treatment

Also Published As

Publication number Publication date
EP0759942A1 (de) 1997-03-05
EP0759942B1 (de) 2003-03-05
DE69529822D1 (de) 2003-04-10
WO1995030695A1 (en) 1995-11-16
DE69529822T2 (de) 2003-12-11
NZ285292A (en) 1998-08-26
ES2193192T3 (es) 2003-11-01
US5591630A (en) 1997-01-07
CA2188279C (en) 2010-01-26
AU2434495A (en) 1995-11-29
PT759942E (pt) 2003-07-31
CA2188279A1 (en) 1995-11-16
EP0759942A4 (de) 1999-05-12
DK0759942T3 (da) 2003-06-10
AU695798B2 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
DK0759942T3 (da) Interleukin-15-receptorer
IL98205A0 (en) Type ii interleukin-1 receptors
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
PL365177A1 (en) Mammalian cytokine receptor subunit proteins, related reagents and methods
UA41888C2 (uk) Злитий білок, який складається з мишачого або олюдненого моноклонального антитіла мав425 або його фрагменту, який спрямовано проти пухлинної клітини, спосіб його отримання, фармацевтична композиція
EP0318296A3 (de) Interleukin 1-Rezeptoren
NL300008I2 (nl) Tumornecrosis factor-alfa en -bet-receptors.
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
ATE118036T1 (de) Interleukin-7-rezeptoren.
HUT57827A (en) Recombinant protein receptor and process for producing same
DK0496818T3 (da) IgA-receptor-specifikt monoklonalt antistof
EP2292760A3 (de) Säuger Zytokine, Receptoren, verwandte Reagentien und Methoden
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
SI1181366T2 (sl) Sesalski receptorski proteini; sorodni reagenti in postopki
ATE58172T1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
MX9802730A (es) Agonistas receptores hematopoyeticos multifuncionales.
NZ515382A (en) OX2 receptor homologs
DK0494260T3 (da) Receptorer for granulocytkolonistimulerende faktor
HUP9801062A2 (hu) Új PKA-kötődő fehérjék, és ezek alkalmazása
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
CY1114280T1 (el) Αντισωματα ανταγωνιστων των κυτοκινων θηλαστικων ή οι υποδοχεις τους για την αγωγη της αλλεργιας

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0759942

Country of ref document: EP